Order Article Reprints

Stanciu I-M, Parosanu AI, Orlov-Slavu C, Iaciu IC, Popa AM, Olaru CM, Pirlog CF, Vrabie RC, Nitipir C. Mechanisms of Resistance to CDK4/6 Inhibitors and Predictive Biomarkers of Response in HR+/HER2-Metastatic Breast Cancer—A Review of the Literature. Diagnostics. 2023; 13(5):987. https://doi.org/10.3390/diagnostics13050987

Stanciu, Ioana-Miruna, Andreea Ioana Parosanu, Cristina Orlov-Slavu, Ion Cristian Iaciu, Ana Maria Popa, Cristina Mihaela Olaru, Cristina Florina Pirlog, Radu Constantin Vrabie, and Cornelia Nitipir. 2023. "Mechanisms of Resistance to CDK4/6 Inhibitors and Predictive Biomarkers of Response in HR+/HER2-Metastatic Breast Cancer—A Review of the Literature" Diagnostics 13, no. 5: 987. https://doi.org/10.3390/diagnostics13050987

Stanciu, I.-M., Parosanu, A. I., Orlov-Slavu, C., Iaciu, I. C., Popa, A. M., Olaru, C. M., Pirlog, C. F., Vrabie, R. C., & Nitipir, C. (2023). Mechanisms of Resistance to CDK4/6 Inhibitors and Predictive Biomarkers of Response in HR+/HER2-Metastatic Breast Cancer—A Review of the Literature. Diagnostics, 13(5), 987. https://doi.org/10.3390/diagnostics13050987